Delivery Order SPE2DR25D1205-SPE2DR26F0VR5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Montelukast Sodium 10 mg tablets in a quantity of 500 units, with a firm fixed price ceiling value of $1,081.72. The contract was competitively awarded without a set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,617.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Montelukast Sodium 10 mg, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger prime contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,366.73 to AmerisourceBergen Drug Corp for the supply of Montelukast Sodium 5 mg chewable tablets (90-count packaging). The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be delivered from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,242 to Amerisourcebergen Drug Corporation to supply 1,000 tablets of montelukast sodium 10 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 11-12, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for a common asthma medication supports...
- The Defense Logistics Agency awarded a $9,780 delivery order to Amerisourcebergen Drug Corporation for the supply of 90 boxes of Montelukast sodium 10 mg tablets. The contract has a firm fixed price and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania between September 8-11, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this delivery order for a common asthma medication supports the Agency's mission to provide essential...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 1,000 bottles of Montelukast Sodium 10 mg tablets, a medication used to treat asthma and allergies. The total ceiling value of the contract is $1,727.93, and it is a firm fixed-price delivery order with an ultimate completion date of August 8, 2024. This order is not associated with a set-aside program....
- The Defense Logistics Agency awarded a $158,550 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 packages containing 4 mg tablets of montelukast sodium to be delivered to a facility in Conshohocken, Pennsylvania by June 27, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for montelukast sodium tablets supports the Agency's mission to provide essential materiel to military customers....
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 1,000 tablets of the pharmaceutical drug Montelukast Sodium 10 mg. The total potential value of this award is $1,223.64, with a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order and is not subject to any set-aside...
- This federal contract award, valued at $1,638.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Montelukast Sodium 10 mg Tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Montelukast Sodium 10 mg tablets. The award, valued at $1,171.19, is a firm fixed-price delivery order contract with an ultimate completion date of August 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VR5Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,035.08 for 1,000 tablets of Montelukast Sodium 10 mg on October 23, 2025, with an ultimate completion date of October 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Montelukast is a commonly prescribed leukotriene receptor antagonist used in the treatment of asthma and allergic rhinitis, representing a routine pharmaceutical supply requirement for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications, vaccines, and medical supplies to support military healthcare programs worldwide through the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract history demonstrates consistent capability in meeting competitive procurement requirements across diverse therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/23/25 |